CLINICAL_TRIALS
trial_result
· 2015-01-12
Clinical Trial Update: Comparative Bioavailability Study of Two Different Sources of Eslicarbazepine Acetate [Phase 1]
Summary
This document reports a Phase 1 comparative bioavailability study of two sources of eslicarbazepine acetate conducted by Bial - Portela C S.A.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bial - Portela C S.A. | Conditions: Epilepsy | Phase 1 | Status: COMPLETED | Results posted: 2015-01-12